141 related articles for article (PubMed ID: 36435987)
1. Dihydroorotate dehydrogenase inhibitor olorofim has potent in vitro activity against Microascus/Scopulariopsis, Rasamsonia, Penicillium and Talaromyces species.
Wiederhold NP; Patterson HP; Sanders CJ; Cañete-Gibas C
Mycoses; 2023 Mar; 66(3):242-248. PubMed ID: 36435987
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of the novel antifungal olorofim against dermatophytes and opportunistic moulds including Penicillium and Talaromyces species.
Singh A; Singh P; Meis JF; Chowdhary A
J Antimicrob Chemother; 2021 Apr; 76(5):1229-1233. PubMed ID: 33421073
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes.
Badali H; Cañete-Gibas C; Patterson H; Sanders C; Mermella B; Garcia V; Mele J; Fan H; Wiederhold NP
Mycoses; 2021 Jul; 64(7):748-752. PubMed ID: 33755988
[TBL] [Abstract][Full Text] [Related]
4. Antifungal Susceptibility Profiles of Olorofim (Formerly F901318) and Currently Available Systemic Antifungals against Mold and Yeast Phases of
Zhang J; Liu H; Xi L; Chang YC; Kwon-Chung KJ; Seyedmousavi S
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33753341
[No Abstract] [Full Text] [Related]
5. In vitro activity of olorofim (F901318) against fungi of the genus, Scedosporium and Rasamsonia as well as against Lomentospora prolificans, Exophiala dermatitidis and azole-resistant Aspergillus fumigatus.
Kirchhoff L; Dittmer S; Buer J; Rath PM; Steinmann J
Int J Antimicrob Agents; 2020 Sep; 56(3):106105. PubMed ID: 32721601
[TBL] [Abstract][Full Text] [Related]
6. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
Wiederhold NP; Law D; Birch M
J Antimicrob Chemother; 2017 Jul; 72(7):1977-1980. PubMed ID: 28333310
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of olorofim against clinical isolates of Scedosporium species and Lomentospora prolificans using EUCAST and CLSI methodologies.
Rivero-Menendez O; Cuenca-Estrella M; Alastruey-Izquierdo A
J Antimicrob Chemother; 2020 Dec; 75(12):3582-3585. PubMed ID: 32856079
[TBL] [Abstract][Full Text] [Related]
8.
Georgacopoulos O; Nunnally N; Law D; Birch M; Berkow EL; Lockhart SR
Microbiol Spectr; 2023 Feb; 11(1):e0278922. PubMed ID: 36629417
[No Abstract] [Full Text] [Related]
9. EUCAST Determination of Olorofim (F901318) Susceptibility of Mold Species, Method Validation, and MICs.
Jørgensen KM; Astvad KMT; Hare RK; Arendrup MC
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784842
[TBL] [Abstract][Full Text] [Related]
10. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
Pfaller MA; Messer SA; Hollis RJ; Jones RN;
Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586
[TBL] [Abstract][Full Text] [Related]
11. Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei.
Lackner M; Birch M; Naschberger V; Grässle D; Beckmann N; Warn P; Gould J; Law D; Lass-Flörl C; Binder U
J Antimicrob Chemother; 2018 Nov; 73(11):3068-3073. PubMed ID: 30351438
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies.
Rivero-Menendez O; Cuenca-Estrella M; Alastruey-Izquierdo A
J Antimicrob Chemother; 2019 Jun; 74(6):1586-1590. PubMed ID: 30891600
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Skóra M; Bulanda M; Jagielski T
Antimicrob Agents Chemother; 2015 Sep; 59(9):5827-9. PubMed ID: 26100698
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents.
Georgacopoulos O; Nunnally NS; Ransom EM; Law D; Birch M; Lockhart SR; Berkow EL
J Fungi (Basel); 2021 May; 7(5):. PubMed ID: 34065811
[TBL] [Abstract][Full Text] [Related]
15. EUCAST-Obtained Olorofim MICs against Aspergillus and Scedosporium Species and Lomentospora prolificans Showed High Agreements between Visual Inspection and Spectrophotometric Readings.
Escribano P; Gómez A; Reigadas E; Muñoz P; Guinea J;
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0084922. PubMed ID: 35924916
[TBL] [Abstract][Full Text] [Related]
16. Antibiofilm activity of antifungal drugs, including the novel drug olorofim, against Lomentospora prolificans.
Kirchhoff L; Dittmer S; Weisner AK; Buer J; Rath PM; Steinmann J
J Antimicrob Chemother; 2020 Aug; 75(8):2133-2140. PubMed ID: 32386411
[TBL] [Abstract][Full Text] [Related]
17. Review of the Novel Investigational Antifungal Olorofim.
Wiederhold NP
J Fungi (Basel); 2020 Jul; 6(3):. PubMed ID: 32751765
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of olorofim against Aspergillus fumigatus sensu lato clinical isolates: activity is retained against isolates showing resistance to azoles and/or amphotericin B.
Escribano P; Gómez A; Reigadas E; Muñoz P; Guinea J;
Clin Microbiol Infect; 2022 Sep; 28(9):1291.e7-1291.e10. PubMed ID: 35597509
[TBL] [Abstract][Full Text] [Related]
19. Olorofim Susceptibility Testing of 1,423 Danish Mold Isolates Obtained in 2018-2019 Confirms Uniform and Broad-Spectrum Activity.
Astvad KMT; Jørgensen KM; Hare RK; Datcu R; Arendrup MC
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33020160
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
Wang HC; Hsieh MI; Choi PC; Wu CJ
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
